Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study

  1. Martin, M.
  2. Brase, J.C.
  3. Ruiz, A.
  4. Prat, A.
  5. Kronenwett, R.
  6. Calvo, L.
  7. Petry, C.
  8. Bernard, P.S.
  9. Ruiz-Borrego, M.
  10. Weber, K.E.
  11. Rodriguez, C.A.
  12. Alvarez, I.M.
  13. Segui, M.A.
  14. Perou, C.M.
  15. Casas, M.
  16. Carrasco, E.
  17. Caballero, R.
  18. Rodriguez-Lescure, A.
Revista:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Any de publicació: 2016

Volum: 156

Número: 1

Pàgines: 81-89

Tipus: Article

DOI: 10.1007/S10549-016-3725-Z GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible